文献速递间质性肺疾病

澳大利亚特发性肺纤维化的发病率、患病率与死亡率

Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia.
PubMed 文献 · Respirology · 2021-12-21

本研究利用MIAMOD方法和疾病-死亡模型,基于澳大利亚统计局1997-2015年数据及澳大利亚IPF登记处数据,首次估算澳大利亚IPF的死亡率、发病率和患病率,并预测至2025年。结果显示粗死亡率和年龄标化死亡率分别为5.9/10万和6.3/10万,发病率分别为10.4/10万和11.2/10万,患病率分别为32.6/10万和35.1/10万,研究期间均上升但预测期呈下降趋势。

要点

  • 澳大利亚IPF年龄标化死亡率为6.3/10万,发病率为11.2/10万,患病率为35.1/10万。
  • 70岁以上人群占总人口9%,但占所有死亡、发病和患病病例约82%-83%。
  • 所有估算值男性均高于女性。

核心结论

  • 本研究首次提供了澳大利亚IPF的发病率、患病率和死亡率估算。

研究设计与样本

  • 采用MIAMOD方法和软件基于疾病-死亡模型生成估算,数据输入包括澳大利亚统计局1997-2015年人口与死亡数据及澳大利亚IPF登记处参与者数据,并预测至2025年。

主要发现

  • 粗死亡率和年龄标化死亡率分别为5.9/10万和6.3/10万。
  • 粗发病率和年龄标化发病率分别为10.4/10万和11.2/10万。
  • 粗患病率和年龄标化患病率分别为32.6/10万和35.1/10万。
  • 研究期间粗及年龄标化的死亡率、发病率和患病率均上升,但预测期呈下降趋势。
  • 70岁以上人群占总人口9%,却占所有死亡、发病和患病病例约82%-83%,且所有估算值男性高于女性。

临床怎么用

  • 研究结果为IPF相关政策制定、规划和优化患者管理资源配置提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung diseases. While studies have been conducted in other countries to determine the epidemiological burden of IPF, there is limited information in Australia. Our study aimed to address this gap and generate the first estimates for the mortality, incidence and prevalence of IPF in Australia. METHODS: Estimates were generated by utilizing the novel Mortality Incidence Analysis Model (MIAMOD) method and software based on the illness-death model. Data inputs included population estimates and mortality data from the Australian Bureau of Statistics (ABS) for the period 1997-2015 and participant data from the Australian IPF Registry (AIPFR). Projections were estimated for a 10-year period up to 2025. RESULTS: Overall crude and age-standardized estimates for mortality were 5.9 and 6.3 per 100,000 population; incidence, 10.4 and 11.2 per 100,000 population; and prevalence, 32.6 and 35.1 per 100,000 population. Crude and age-standardized mortality, incidence and prevalence increased over the study period; however, they demonstrated a decreasing trend over the projected period. Persons older than 70 years constituted 9% of the population; however, they accounted for approximately 82%-83% of all deaths, incident and prevalent cases. All estimates were higher in males than in females. CONCLUSION: Our study provides the first estimates for incidence, prevalence and mortality of IPF in Australia. By reporting national estimates for IPF, our study addresses an information gap important for policy, planning and to help optimize the allocation of resources for the management of patients with IPF.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Cox IA, Otahal P, de Graaff B, et al. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology. 2021. PMID: 34935240. doi:10.1111/resp.14194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。